Deyun Chen

Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming

Yao Wang, Chuan Tong, Hanren Dai et al. · Nature Communications · 2021 · 216 citations · Full text

Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial

Hanren Dai, Chuan Tong, Daiwei Shi et al. · OncoImmunology · 2020 · 165 citations · Full text

Hypoxia Regulates the Therapeutic Potential of Mesenchymal Stem Cells Through Enhanced Autophagy

Jiejie Liu, Haojie Hao, Hong Huang et al. · The International Journal of Lower Extremity Wounds · 2015 · 58 citations

CD58 loss in tumor cells confers functional impairment of CAR T cells

Xin Yan, Deyun Chen, Xinran Ma et al. · Blood Advances · 2022 · 56 citations · Full text

Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies

Xin Yan, Deyun Chen, Yao Wang et al. · Signal Transduction and Targeted Therapy · 2022 · 50 citations · Full text